Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease
Launched by MCGILL UNIVERSITY · Oct 27, 1999
Trial Information
Current as of March 19, 2025
Completed
Keywords
ClinConnect Summary
BACKGROUND:
The potential importance of respiratory, chiefly inspiratory-muscle, fatigue had only recently been appreciated. If inspiratory muscles fail, so does ventilation and tissue respiration. There are theoretical reasons to postulate inspiratory muscle failure in chronic obstructive pulmonary disease, and suggestions that it may occur in an acute form with exacerbations and in a chronic form during 'stability'. There are two therapeutic strategies available for prevention and treatment of inspiratory muscle fatigue: training inspiratory muscles to increase their efficiency and resti...
Gender
ALL
Eligibility criteria
- • No eligibility criteria
Trial Officials
Peter Macklem
Principal Investigator
McGill University
About Mcgill University
McGill University, a prestigious research institution located in Montreal, Canada, is committed to advancing medical science through innovative clinical trials. Renowned for its rigorous academic standards and collaborative approach, McGill fosters a dynamic environment that integrates cutting-edge research with clinical practice. With a focus on improving patient outcomes, the university's clinical trials span a wide range of therapeutic areas, leveraging the expertise of its diverse faculty and state-of-the-art facilities. McGill University is dedicated to ethical research practices and the dissemination of knowledge, ensuring that findings contribute meaningfully to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials